These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20701719)

  • 41. Polyunsaturated fatty acids and cardiovascular disease.
    Calzolari I; Fumagalli S; Marchionni N; Di Bari M
    Curr Pharm Des; 2009; 15(36):4094-102. PubMed ID: 20041811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of protein intake variation and omega-3 polyunsaturated fatty acids on renal function in chronic renal disease.
    Schaap GH; Bilo HJ; Popp-Snijders C; Oe PL; Mulder C; Donker AJ
    Life Sci; 1987 Dec; 41(25):2759-65. PubMed ID: 3695805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The benefits and risks of n-3 polyunsaturated fatty acids.
    Takahata K; Monobe K; Tada M; Weber PC
    Biosci Biotechnol Biochem; 1998 Nov; 62(11):2079-85. PubMed ID: 9972229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia.
    Di Girolamo FG; Situlin R; Mazzucco S; Valentini R; Toigo G; Biolo G
    Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):145-50. PubMed ID: 24500439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omega-3 fatty acids: recommendations for therapeutics and prevention.
    Hutchins H; Vega CP
    MedGenMed; 2005 Oct; 7(4):18. PubMed ID: 16614640
    [No Abstract]   [Full Text] [Related]  

  • 46. Omega-3 and renal function in older adults.
    Lauretani F; Maggio M; Pizzarelli F; Michelassi S; Ruggiero C; Ceda GP; Bandinelli S; Ferrucci L
    Curr Pharm Des; 2009; 15(36):4149-56. PubMed ID: 20041816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic Effects of Omega-3 Fatty Acids on Chronic Kidney Disease-Associated Pruritus: a Literature Review.
    Panahi Y; Dashti-Khavidaki S; Farnood F; Noshad H; Lotfi M; Gharekhani A
    Adv Pharm Bull; 2016 Dec; 6(4):509-514. PubMed ID: 28101457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supplementation of n-3 polyunsaturated fatty acids to prevent postoperative atrial fibrillation in patients subjected to heart surgery.
    Messori A; Fadda V; Maratea D
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):991-2. PubMed ID: 24041165
    [No Abstract]   [Full Text] [Related]  

  • 49. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association.
    Kris-Etherton PM; Harris WS; Appel LJ;
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):151-2. PubMed ID: 12588750
    [No Abstract]   [Full Text] [Related]  

  • 50. CKD: it does not have to be the harbinger of cardiac doom.
    Baum SJ
    Nephrol News Issues; 2008 Oct; 22(11):32, 34, 36. PubMed ID: 19009858
    [No Abstract]   [Full Text] [Related]  

  • 51. Omega-3 polyunsaturated fatty acid supplementation in chronic kidney disease and its effects on cardiovascular mortality and kidney disease progression.
    Kumar A; Shariff M
    Clin Nutr; 2019 Oct; 38(5):2460-2461. PubMed ID: 31375302
    [No Abstract]   [Full Text] [Related]  

  • 52. Omega-3-rich food: good for your heart. Learn what these essential fatty acids can do for your cardiovascular health, and where to find the best sources.
    Harv Womens Health Watch; 2013 Nov; 21(3):3. PubMed ID: 27024796
    [No Abstract]   [Full Text] [Related]  

  • 53. n-3 Fatty acids and their role in nephrologic practice.
    Donadio JV
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):639-42. PubMed ID: 11496058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omega-3 and serum homocysteine level in hemodialysis patients.
    Savaj S
    Iran J Kidney Dis; 2013 Nov; 7(6):421-2. PubMed ID: 24241084
    [No Abstract]   [Full Text] [Related]  

  • 55. Dietary concerns in patients with advanced chronic kidney disease introduction.
    Ikizler TA
    Semin Dial; 2010; 23(4):351-2. PubMed ID: 20701714
    [No Abstract]   [Full Text] [Related]  

  • 56. Dietary fat, fiber, and acne vulgaris.
    Logan AC
    J Am Acad Dermatol; 2007 Dec; 57(6):1092-3. PubMed ID: 18021854
    [No Abstract]   [Full Text] [Related]  

  • 57. Studying Muscle Protein Turnover in CKD.
    Garibotto G; Verzola D
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1131-1132. PubMed ID: 27281697
    [No Abstract]   [Full Text] [Related]  

  • 58. Protective effect of ω-3 polyunsaturated fatty acids (PUFAs) on sodium nitroprusside-induced nephrotoxicity and oxidative damage in rat kidney.
    Khan MW; Priyamvada S; Khan SA; Khan S; Naqshbandi A; Yusufi AN
    Hum Exp Toxicol; 2012 Oct; 31(10):1035-49. PubMed ID: 22549094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consumption of long-chain n-3 PUFA, α-linolenic acid and fish is associated with the prevalence of chronic kidney disease.
    Gopinath B; Harris DC; Flood VM; Burlutsky G; Mitchell P
    Br J Nutr; 2011 May; 105(9):1361-8. PubMed ID: 21255476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study.
    Madsen T; Christensen JH; Svensson M; Witt PM; Toft E; Schmidt EB
    J Ren Nutr; 2011 Mar; 21(2):169-75. PubMed ID: 20833075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.